ConductScience.org, home
TPM2: tropomyosin 2
API referenceFor AI assistants

Gene · 7169

Papers1,629

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,629

Download this page as JSON
TitleJournalYearPMIDFound bySource
Fibroblast-associated TPM2 links cell-matrix remodeling to EMT-Notch signaling and gemcitabine resistance in intrahepatic cholangiocarcinoma.Cancer Biol Ther202642766730PubTator, text miningPubMed
Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment.Front Cell Dev Biol202642729537PubTator, text miningPubMed
Discovery of DA1 as PARP inhibitor for the treatment of BRCA-proficient triple negative breast cancer by suppressing the PI3K/AKT/mTOR signaling pathway.Bioorg Med Chem202642531674PubTator, text miningPubMed
Clinical and Molecular Heterogeneity of MYH3-Related Arthrogryposis with a Novel MYH3 Variant.Genes (Basel)202642510802PubTator, text miningPubMed
Disease-associated mutations in TPM2 alter regulation of actin filament stability and cofilin-dependent dynamics.bioRxiv202642239403PubTator, text miningPubMed
Protein expression profiling of lenvatinib-resistant liver cancer cells and identify B4GALT4 as a critical drug resistance molecule.Discov Oncol202642091754PubTator, text miningPubMed
Dynamic immune landscape of NAFLD highlights pDCs as predictive biomarkers for disease progression.Front Immunol202642039185PubTator, text miningPubMed
Peptide-drug conjugates bearing an antimitotic Ahx-DA1 payload achieve potent antitumor activity in Her2-amplified and EGFR-positive KRAS-mutant cancers in vivo.Bioorg Med Chem202642033924PubTator, text miningPubMed
Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics.Prostate202641911496PubTator, text miningPubMed
Integrated transcriptomics and proteomics analysis reveal potential target in pediatric primary restrictive cardiomyopathy.Pediatr Res202641876697PubTator, text miningPubMed
Chemoradiotherapy facilitates siglec-10+/siglec-9+ macrophage-mediated impairment of CD24+/MUC16+ tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.Cancer Immunol Immunother202641801406PubTator, text miningPubMed
Genetic diversity and molecular characterization of avian paramyxoviruses from wild birds in South Korea between 2020 and 2024.Front Microbiol202641783500PubTator, text miningPubMed
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.Sci Adv202641758938PubTator, text miningPubMed
Exploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches.Clin Exp Med202641739231PubTator, text miningPubMed
Top-Down Proteomics of Skinned Human Muscle Fibers Reveals Proteoform-Resolved Fiber-to-Fiber Variability.J Mass Spectrom202641725242PubTator, text miningPubMed
Cancer-associated fibroblasts are associated with CD8+ T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi-omics and machine learning analysis.J Pathol Clin Res202641725109PubTator, text miningPubMed
Rabies, host population structure, and cross-species transmission to the migratory bat Tadarida brasiliensis in Chile.PLoS Negl Trop Dis202641712612PubTator, text miningPubMed
Linking cortical structure and delirium in the elderly: insights from cohort study and shared genetic risk analysis.J Transl Med202641680881PubTator, text miningPubMed
COL14A1 drives ischemic cardiac injury in PCOS: an artificial intelligence-identified biomarker.QJM202641619759PubTator, text miningPubMed
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.J Immunother Cancer202641592893PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7169/papers

API referenceFor AI assistants